Femitraz Tablet

Femitraz Tablet is a medication crucial in treating specific types of breast cancer. It contains Anastrozole which belongs to a class of drugs known as aromatase inhibitors.

It operates by inhibiting an enzyme called aromatase, responsible for estrogen production. Reduction of estrogen levels, achieved by blocking aromatase, proves effective in slowing down or halting the growth of estrogen-sensitive breast cancers. In simpler terms, Anastrozole is employed to counteract the effects of estrogen, significantly benefiting the treatment of certain breast cancers.

By impeding the action of the aromatase enzyme, Anastrozole effectively diminishes estrogen levels in the body. Since some breast cancers depend on estrogen for their growth, this reduction in estrogen serves to hinder cancer progression.

Adherence to your doctor's instructions is vital while using it. The medication can be taken with or without food, but maintaining a consistent daily schedule is recommended for optimal results.

Its usage may result in decreased bone mineral density, elevating the risk of fractures. Regular monitoring of bone health is advised, particularly in postmenopausal women. Adequate intake of calcium and vitamin D, coupled with weight-bearing exercise, may be recommended. Postmenopausal women taking Anastrozole might face an increased risk of osteoporosis, necessitating bone density testing and preventive measures.

Side effects of it may include diarrhea, nausea, osteoporosis, headache, vaginal bleeding, vaginal dryness, sensory disturbance, hot flushes, hair loss, bone pain, and hypercholesterolemia.

If a dose is missed, take it when recalled If the next dose is imminent, skip the missed one and adhere to the regular schedule. Avoid doubling doses. Seek advice from your doctor on managing missed doses effectively. The completion of the prescribed course is crucial for optimal therapeutic outcomes.